Rianthavorn Pornpimol, Chacranon Manunya
Division of Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, 1873 King Rama 4 Road, Pathumwan, Bangkok, 10330, Thailand.
Clin Exp Nephrol. 2018 Jun;22(3):661-667. doi: 10.1007/s10157-017-1498-2. Epub 2017 Nov 3.
Information on long-term renal outcome of pediatric glomerulonephritis associated with crescent formation is limited. A single center retrospective study was conducted to assess long-term renal survival and to determine whether the 2010 classification for antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis can predict renal outcome in pediatric glomerulonephritis associated with crescent formation.
Biopsy and clinical data of children, aged ≤ 18 years with ≥ 10 glomeruli and ≥ 10% crescentic glomeruli during January 1998 to December 2015, were reviewed. Biopsies were classified according to the 2010 classification into focal, crescentic, mixed, and sclerotic classes. The clinical endpoint was end-stage renal disease (ESRD).
Of 72 children, 14 patients (19.4%) had positive ANCA. The biopsy indication was rapidly progressive glomerulonephritis in 38 patients (52.8%) and 22 patients (30.6%) required dialysis at onset. Lupus nephritis was the most common diagnosis (43.1%), followed by IgA nephropathy/Henoch-Schoenlein purpura (HSP) (22.2%). ESRD occurred in 18 patients (25%) and the risk of ESRD differed among the histological classifications (p < 0.001). Dialysis at onset and sclerotic class was independent predictors of ESRD in an adjusted model. The risk of ESRD was four-fold higher in patients requiring dialysis at onset and 7.7-fold higher in sclerotic patients than in crescentic patients.
The probability of ESRD was substantial in pediatric glomerulonephritis associated with crescent formation. The 2010 classification is useful for establishing long-term renal prognosis. Future research is required to validate whether histological classification could be a determinant in therapeutic guideline modification, since long-term renal prognosis is different in each class.
关于小儿新月体形成相关肾小球肾炎的长期肾脏转归的信息有限。开展了一项单中心回顾性研究,以评估长期肾脏生存率,并确定2010年抗中性粒细胞胞浆抗体(ANCA)相关肾小球肾炎分类能否预测小儿新月体形成相关肾小球肾炎的肾脏转归。
回顾了1998年1月至2015年12月期间年龄≤18岁、肾小球≥10个且新月体肾小球≥10%的儿童的活检及临床资料。活检根据2010年分类分为局灶性、新月体性、混合性和硬化性类别。临床终点为终末期肾病(ESRD)。
72例儿童中,14例(19.4%)ANCA阳性。活检指征为急进性肾小球肾炎的有38例(52.8%),22例(30.6%)起病时需要透析。狼疮性肾炎是最常见的诊断(43.1%),其次是IgA肾病/过敏性紫癜(HSP)(22.2%)。18例(25%)发生ESRD,ESRD风险在组织学分类中存在差异(p<0.001)。在调整模型中,起病时透析和硬化性类别是ESRD的独立预测因素。起病时需要透析的患者发生ESRD的风险是新月体性患者高4倍,硬化性患者发生ESRD的风险是新月体性患者高7.7倍。
小儿新月体形成相关肾小球肾炎发生ESRD的可能性很大。2010年分类有助于确立长期肾脏预后。由于各分类的长期肾脏预后不同,未来需要开展研究以验证组织学分类是否可作为修改治疗指南的决定因素。